Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 August, 2017 10:44 IST
Glenmark Pharma secures USFDA nod for Clobetasol Propionate ointment
Source: IRIS | 21 Mar, 2017, 09.44AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Ointment USP, 0.05%, the generic version of Temovate Ointment, 0.05% of Fougera Pharmaceuticals Inc.

According to IMS Health sales data for the 12 month period ending January 2017, the Temovate Ointment, 0.05% market1 achieved annual sales of approximately USD 175.3 million.

Glenmark's current portfolio consists of 113 products authorized for distribution in the U.S. marketplace and approximately 64 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark (Q,N,C,F)* continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Shares of the company gained Rs 0.9, or 0.1%, to trade at Rs 881.25. The total volume of shares traded was 6,211 at the BSE (9.35 a.m., Tuesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Dr Reddy's to get up to USD 32.5 mn in milestone payments for DFD-06 - 22-Aug-2017 10:33
Eros International Media's promoter completes sale of 11.8 mn shares - 22-Aug-2017 10:22
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
HCL Infosystems to distribute Apple products in Indian market - 22-Aug-2017 10:05
Lupin receives EIR from USFDA for Aurangabad facility - 22-Aug-2017 10:02
McNally Bharat bags order worth Rs 5.14 bn - 22-Aug-2017 09:58
TCS' arm to deploy digital learning platform for ICSI - 21-Aug-2017 16:09
Jubilant receives NDA approval for Drax Exametazime - 21-Aug-2017 15:07
Tata Power launches electric vehicle charging infrastructure in Mumbai - 21-Aug-2017 13:54
Blue Star wins multiple MEP orders of over Rs 5 bn - 21-Aug-2017 12:03
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer